Clinical trials
Acute Ischemic Stroke clinical trials
Below are recruiting acute ischemic stroke clinical trials, each written for real people, not researchers. We’re tracking 458 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01364168Recruiting
Study of new stroke patients and what happens next
This study follows people after a first acute ischemic stroke (a blockage-related stroke) to learn what to expect in the days and months after. Your participation could help doctors better understand recovery and outcomes and improve future care.
BerlinAges 18 years+ - NCT02369770Recruiting
Rehab training for ankle and leg function after a stroke
This study tests a sensory-motor rehabilitation program to improve movement of the ankle and affected leg after a first stroke. It may help people regain safer, more controlled walking and leg movement.
Baltimore, MarylandAges 18–80 - NCT06702787Enrolling by invitation
Mechanical thrombectomy for stroke in the Middle East and North Africa
This study collects information from people who had a stroke from a blocked brain artery and were treated with mechanical thrombectomy (a procedure to remove the clot). The goal is to understand how well this treatment works in the Middle East and North Africa.
Alexandria, Alexandria GovernorateAges Any age - NCT04971564Recruiting
Blood inflammation test study in sudden brain oxygen loss
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
Paris, Île-de-France RegionAges 18 years+ - NCT06954155RecruitingPhase 3
Tenecteplase for stroke treatment 24-72 hours after symptoms start
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
BeijingAges 18 years+ - NCT07742020Recruiting
Movement therapy comparison for stroke recovery
This study compares two rehabilitation techniques to help people who have had a stroke regain movement in their arm or leg. It aims to find which method works better for improving daily function during the recovery phase.
Lahore, Punjab ProvinceAges 45–65 - NCT04667078RecruitingPhase 3
Cangrelor plus thrombectomy to improve blood flow imaging in stroke
This Phase 3 trial tests whether adding a clot-fighting medicine called cangrelor to a mechanical clot-removal procedure (thrombectomy) can improve outcomes in selected acute stroke patients. It targets people whose scan shows there may be salvageable brain tissue, aiming to protect more brain while the clot is treated.
BesançonAges 18–80 - NCT06479174Recruiting
Cognitive strategies after stroke with family support
This study tests if combining cognitive exercises with a safe, mild brain stimulation can help improve memory and thinking after a stroke. It also looks at how shared family health history might affect recovery.
Albuquerque, New MexicoAges 18 years+ - NCT05378035Recruiting
DOAC interruption study for Chinese people with atrial fibrillation
This trial studies how safely and effectively to pause a blood thinner (a DOAC) for about 48 hours before an elective procedure in people with atrial fibrillation. It may help confirm the best way to reduce bleeding risk without raising stroke risk.
Hong KongAges 18–80 - NCT05793177Recruiting
Monitoring light movement after stroke rehabilitation
This study checks whether tracking sitting time and light activity after stroke is helpful for recovery during rehabilitation. You would be monitored for daily movement, and the researchers want to see how activity patterns relate to recovery.
RoskildeAges Any age - NCT06244914Recruiting
Combined brain stimulation for recovery after recent stroke
This trial tests if combining two kinds of gentle brain stimulation can help people recover better after a recent stroke. It's for people who had a clot-caused stroke in the upper part of the brain and still have some weakness on one side.
Tainan, TainanAges 18 years+ - NCT06928675Recruiting
Cell-free DNA in acute stroke
This study looks at how a substance called cell-free DNA in the blood changes in people with a large blood clot causing a stroke. It aims to improve understanding of this condition and might help with future treatments.
BaselAges 18 years+ - NCT07381491Recruiting
Core and hip exercises for balance after stroke
This trial tests if adding special hip exercises to core strengthening can improve trunk control and balance in people who had a stroke 2 weeks to 6 months ago. It may help those who can still walk a little.
Rawalpindi, Punjab ProvinceAges 45–60 - NCT06551727Enrolling by invitation
Stroke progression treatment: blood pressure and antiplatelet therapy
This trial tests a combination of blood pressure control and antiplatelet therapy for people whose stroke symptoms are getting worse. It is looking for those without a large brain artery clot or heart-related cause.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06404268RecruitingPhase 1/Phase 2
Helping stroke survivors regain ankle movement with exercise
This study tests whether gentle leg exercises can help people recovering from a recent stroke. The focus is on improving ankle movement and strength on the weak side.
Baltimore, MarylandAges 30–85 - NCT04701684Recruiting
Fast-stroke treatment workflow study to save minutes to clot removal
This study tests whether a streamlined hospital workflow can reduce the time it takes to reopen blocked blood vessels during very fast stroke treatment. Faster treatment may help more brain tissue be saved by getting endovascular (clot-removal) therapy started sooner.
Jacksonville, FloridaAges 18 years+ - NCT05556395Recruiting
Study after stroke to help thinking and memory recovery
This trial looks at stroke patients who can show specific scan findings on an MRI, then uses thinking tests by phone to track cognitive (thinking and memory) changes. It may help researchers understand whether targeting brain blood-flow disruption can improve post-stroke cognition.
Baltimore, MarylandAges 18 years+ - NCT05948566RecruitingPhase 2
Improving response to stroke treatment with an antibody drug
This Phase 2 trial tests an antibody treatment (TS23) given to people with a suspected acute ischemic stroke to improve how well they respond to stroke care. You may qualify if your stroke scan shows the right pattern of injured brain tissue and if the study drug can be given within a short time window after symptoms start.
Birmingham, AlabamaAges 18 years+ - NCT06591299RecruitingPhase 3
Aspirin plus cilostazol or clopidogrel for minor stroke or TIA
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
Kafr ash ShaykhAges 18–75 - NCT06591338RecruitingPhase 3
Aspirin plus ticagrelor or clopidogrel for minor stroke
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
Kafr ash ShaykhAges 18–75 - NCT06591312RecruitingPhase 3
Aspirin plus another drug after minor stroke or TIA
This trial tests whether combining aspirin with a second antiplatelet drug (ticagrelor or clopidogrel) helps prevent another stroke after a mild stroke or TIA. It might lower your risk of having another event.
Kafr ash ShaykhAges 18–75 - NCT06591351RecruitingPhase 3
Aspirin plus cilostazol or clopidogrel for minor stroke or TIA
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
Kafr ash ShaykhAges 18–75 - NCT06591390RecruitingPhase 3
Aspirin plus another drug for minor stroke or TIA
This trial tests whether taking aspirin along with either ticagrelor or cilostazol helps prevent another stroke in people who have had a mild stroke or transient ischemic attack (mini-stroke). You must start treatment within 24 hours of your first symptoms.
Kafr ash ShaykhAges 18–75 - NCT06591377RecruitingPhase 3
Aspirin plus a second drug for minor stroke or TIA
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
CairoAges 18–75
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute ischemic stroke?
- Yes. Clin2 currently lists 458 recruiting acute ischemic stroke studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute ischemic stroke trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute ischemic stroke trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.